Patel Bhavik 4

What Happened

• Bhavik Patel, President, MedTech and Consumer Health at IQVIA (IQV), received a grant of 11,180 stock appreciation rights (SARs) on February 9, 2026. The award was recorded with an acquisition price of $0.00 (derivative award); no cash was exchanged.
• This is an equity compensation award (transaction code A), not a purchase or sale of stock.

Key Details

• Transaction date: 2026-02-09; Form 4 filed: 2026-02-11 (timely filing).
• Instrument: 11,180 stock appreciation rights (SARs) granted at $0.00.
• Vesting: The SARs vest in three annual installments beginning February 9, 2027 (see footnote F1).
• Shares owned after the transaction: not specified in the filing.
• Filing was timely (no late-report indication).

Context

• Stock appreciation rights are a derivative compensation vehicle that gives the holder the right to receive the appreciated value of the stock over a set price; payout depends on future stock performance and vesting. This award is a typical retention/incentive grant and does not by itself indicate an immediate buy or sell decision.